Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TOMMASO ADDONA

Allopathic & Osteopathic Physicians Plastic Surgery

NPI
1306004353
CMS profile
240721
Location
GARDEN CITY, NY

General Payments · PY2018–2024

$15,233.08

  • Reported across 126 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$6,084.24

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $3,000.00 1
Food and Beverage $2,417.57 34
Grant $666.67 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
MOTIVA USA, LLC $3,162.63 2
AXOGEN $791.63 7
ABBVIE INC. $699.08 2
REVANCE THERAPEUTICS, INC. $569.61 10
Galderma Laboratories, L.P. $374.84 6
DAVOL INC. $148.17 1
Solventum Corporation $135.58 1
Mentor Worldwide LLC $87.11 3
Integra LifeSciences Corporation $73.15 2
Stryker Corporation $23.42 1
Merck Sharp & Dohme Corporation $19.02 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $567.05 9
PY2019 $2,048.97 18
PY2020 $256.74 3
PY2021 $1,532.67 26
PY2022 $2,535.97 17
PY2023 $2,207.44 17
PY2024 $6,084.24 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $32.41 03/26/2024 Food and Beverage Undisputed 01/23/2026 1103175346 CMS
ABBVIE INC. $666.67 07/02/2024 Grant Undisputed 01/23/2026 1103136921 CMS
AXOGEN $143.52 06/18/2024 Food and Beverage Undisputed 01/23/2026 1143639198 CMS
AXOGEN $21.46 07/26/2024 Food and Beverage Undisputed 01/23/2026 1143640004 CMS
AXOGEN $123.73 07/26/2024 Food and Beverage Undisputed 01/23/2026 1143640008 CMS
AXOGEN $131.21 08/21/2024 Food and Beverage Undisputed 01/23/2026 1143640699 CMS
AXOGEN $123.58 09/26/2024 Food and Beverage Undisputed 01/23/2026 1143641676 CMS
AXOGEN $94.28 09/27/2024 Food and Beverage Undisputed 01/23/2026 1143641761 CMS
AXOGEN $153.85 10/24/2024 Food and Beverage Undisputed 01/23/2026 1143642399 CMS
Davol Inc. $148.17 11/15/2024 Food and Beverage Undisputed 01/23/2026 1127652089 CMS
Galderma Laboratories, L.P. $59.24 03/08/2024 Food and Beverage Undisputed 01/23/2026 1145282507 CMS
Galderma Laboratories, L.P. $106.44 03/25/2024 Food and Beverage Undisputed 01/23/2026 1145282509 CMS
Galderma Laboratories, L.P. $14.83 06/04/2024 Food and Beverage Undisputed 01/23/2026 1145282511 CMS
Galderma Laboratories, L.P. $3.26 07/18/2024 Food and Beverage Undisputed 01/23/2026 1145282513 CMS
Galderma Laboratories, L.P. $141.49 07/29/2024 Food and Beverage Undisputed 01/23/2026 1145282515 CMS
Galderma Laboratories, L.P. $49.58 08/21/2024 Food and Beverage Undisputed 01/23/2026 1145282517 CMS
Integra LifeSciences Corporation $18.68 02/23/2024 Food and Beverage Undisputed 01/23/2026 1140138310 CMS
Integra LifeSciences Corporation $54.47 03/22/2024 Food and Beverage Undisputed 01/23/2026 1140138306 CMS
Mentor Worldwide LLC $21.80 07/23/2024 Food and Beverage Undisputed 01/23/2026 1077615510 CMS
Mentor Worldwide LLC $33.42 12/10/2024 Food and Beverage Undisputed 01/23/2026 1077615514 CMS
Mentor Worldwide LLC $31.89 12/31/2024 Food and Beverage Undisputed 01/23/2026 1077615500 CMS
Merck Sharp & Dohme LLC $19.02 03/28/2024 Food and Beverage Undisputed 01/23/2026 1141683571 CMS
MOTIVA USA, LLC $162.63 08/07/2024 Food and Beverage Undisputed 01/23/2026 1139154276 CMS
MOTIVA USA, LLC $3,000.00 10/28/2024 Consulting Fee Undisputed 01/23/2026 1139154066 CMS
REVANCE THERAPEUTICS, INC. $41.45 03/14/2024 Food and Beverage Undisputed 01/23/2026 1147911136 CMS
REVANCE THERAPEUTICS, INC. $42.81 04/18/2024 Food and Beverage Undisputed 01/23/2026 1147911138 CMS
REVANCE THERAPEUTICS, INC. $136.24 04/19/2024 Food and Beverage Undisputed 01/23/2026 1147911140 CMS
REVANCE THERAPEUTICS, INC. $75.46 09/04/2024 Food and Beverage Undisputed 01/23/2026 1147911142 CMS
REVANCE THERAPEUTICS, INC. $34.84 09/05/2024 Food and Beverage Undisputed 01/23/2026 1147911144 CMS
REVANCE THERAPEUTICS, INC. $24.05 09/18/2024 Food and Beverage Undisputed 01/23/2026 1147911146 CMS
REVANCE THERAPEUTICS, INC. $96.20 09/18/2024 Food and Beverage Undisputed 01/23/2026 1147911148 CMS
REVANCE THERAPEUTICS, INC. $34.95 11/26/2024 Food and Beverage Undisputed 01/23/2026 1147911150 CMS
REVANCE THERAPEUTICS, INC. $38.61 12/04/2024 Food and Beverage Undisputed 01/23/2026 1147911152 CMS
REVANCE THERAPEUTICS, INC. $45.00 12/10/2024 Food and Beverage Undisputed 01/23/2026 1147911154 CMS
Solventum Corporation $135.58 11/19/2024 Food and Beverage Undisputed 01/23/2026 1144052549 CMS
Stryker Corporation $23.42 11/19/2024 Food and Beverage Undisputed 01/23/2026 1119756498 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.